-

Morris & Dickson Announces Vinu V. Pillai as Chief Compliance and Regulatory Officer

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson today announces that Vinu V. Pillai has joined the company as its chief compliance and regulatory officer. In this role, Pillai will have responsibility for Morris & Dickson’s overall compliance and regulatory functions including ethics management, risk management, suspicious order monitoring, Drug Supply Chain Security Act (DSCSA) oversight, regulatory oversight and licensing, and he will report to Jody Hatcher, president and CEO.

“Vinu brings more than 20 years of experience supporting pharmaceutical and medical device companies, and he has a strong track record of sound ethical conduct and professional judgment,” says Hatcher. “We have invested heavily in growing and strengthening our compliance systems at Morris & Dickson in recent years. Having Vinu join us in this role underscores our continued commitment and focus.”

Pillai previously served as the assistant general counsel at Alto Pharmacy based in San Francisco. Prior to that, he held multiple senior legal and compliance roles at a variety of healthcare companies, including Pear Therapeutics, DaVita and Cencora (formerly AmerisourceBergen). He earned both his undergraduate and law degrees at George Washington University.

About Morris & Dickson

Morris & Dickson is the industry’s largest independent full-line and specialty pharmaceutical distributor with a singular focus of reliable, next-day delivery of drugs and related products to health systems, independent pharmacies, specialty pharmacies, and alternative care facilities, with licensing in all 50 states. Doing business the right way since 1841, Morris & Dickson continues to grow to meet customers’ needs with over 30,000 SKUs of pharmaceutical and healthcare products found in our state-of-the-art, 12-acre automated distribution center, located in Louisiana. For more information, please visit https://www.morrisdickson.com.

Contacts

Cassandra Johnson
SVP, Marketing & Communications
cjohnson@morrisdickson.com
214-288-5471

Morris & Dickson


Release Versions

Contacts

Cassandra Johnson
SVP, Marketing & Communications
cjohnson@morrisdickson.com
214-288-5471

More News From Morris & Dickson

Morris & Dickson and Mark Cuban Cost Plus Drugs: Pioneering a New Era in Medication Access

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson LLC, the nation’s largest independent pharmaceutical distributor, today announced a strategic partnership with Mark Cuban Cost Plus Drug Company and the Cost Plus Marketplace to significantly expand access to critical injectable medications nationwide, addressing key challenges for hospitals, pharmacies, clinics and healthcare providers alike. Transforming Healthcare Through Innovation At the heart of this collaboration lies a shared commit...

Morris & Dickson Announces Expansion of Third-Party Logistics Services with Acquisition of Presa Solutions

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson Inc., a pharmaceutical wholesale and specialty distributor, announced today the acquisition of Presa Solutions, a leading virtual third-party logistics (3PL) company for pharmaceutical manufacturers. This purchase will extend Morris & Dickson’s current service offering for pharmaceutical manufacturer customers with the addition of a 3PL platform that will combine Presa Solutions’ groundbreaking order-to-cash platform with Morris & D...

Morris & Dickson Continues Growth Trajectory with National Licensing for Distribution Across All 50 States

SHREVEPORT, La.--(BUSINESS WIRE)--Morris & Dickson announced today that it is now licensed to deliver pharmaceuticals and related products to health systems, independent pharmacies, specialty pharmacies and alternative care facilities across all 50 states. With a 180-plus year reputation as the leading pharmaceutical distributor in the south-central region of the United States, this national expansion signifies a milestone in M&D’s growth strategy with the ability to serve pharmacies ac...
Back to Newsroom